Impact of antithrombotic medications on postprocedural outcomes of percutaneous endoscopic gastrostomy: a US Collaborative Network study
These findings suggest that while anticoagulant use increases the risk of minor post-PEG bleeding, it does not lead to a higher incidence of severe bleeding. Additionally, the continuation of DAPT was not associated with statistically significant increase in bleeding risk. This study provides valuable insights into the management of antithrombotic therapy in patients undergoing PEG.
Authors
- Khaled Elfert (ORCID: https://orcid.org/0000-0001-5554-6252)
- Mouhand Mohamed (ORCID: https://orcid.org/0000-0002-4761-8014)
- Azizullah Beran (ORCID: https://orcid.org/0000-0002-4161-942X)
- Sherif Elhanafi (ORCID: https://orcid.org/0000-0003-4560-4396)
- Matthew Krafft (ORCID: https://orcid.org/0000-0002-2291-8977)
- Mahmoud Nassar (ORCID: https://orcid.org/0000-0002-5401-9562)
- Hazem Abosheaishaa (ORCID: https://orcid.org/0000-0002-5581-8702)
- Hossam Elbenawi
- Mohammed Abusuliman (ORCID: https://orcid.org/0009-0006-7672-2896)
Institutions
- West Virginia University (US)
- Texas Tech University (US)
- Mayo Clinic (US)
- Henry Ford Health System (US)
- Queens Hospital Center (US)
- Mount Sinai Queens (US)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
- University at Buffalo, State University of New York (US)
- Texas Tech University Health Sciences Center (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- European Journal of Gastroenterology & Hepatology
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1097/meg.0000000000002990
- Primary Topic
- Clinical Nutrition and Gastroenterology
- Type
- article
- Field-Weighted Citation Impact
- 0.00